Group One Trading, L.P. Gamida Cell Ltd. Transaction History

Group One Trading, L.P.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	SELL	$0.04 - $0.46 $1,271 - $14,627	-31,798 Reduced 14.12%	193,472 $7,000
Q4 2023 Feb 14, 2024	BUY	$0.25 - $1.02 $15,648 - $63,843	62,592 Added 38.48%	225,270 $92,000
Q3 2023 Nov 09, 2023	BUY	$0.85 - $1.87 $138,276 - $304,207	162,678 New	162,678 $167,000
Q1 2023 May 12, 2023	BUY	$0.68 - $1.71 $15,120 - $38,023	22,236 Added 219.46%	32,368 $26,000
Q4 2022 Feb 09, 2023	BUY	$1.15 - $2.1 $2,838 - $5,182	2,468 Added 32.2%	10,132 $13,000
Q3 2022 Nov 09, 2022	SELL	$1.53 - $3.39 $14,046 - $31,123	-9,181 Reduced 54.5%	7,664 $12,000
Q2 2022 Aug 11, 2022	BUY	$1.73 - $4.29 $12,283 - $30,459	7,100 Added 72.86%	16,845 $30,000
Q1 2022 May 12, 2022	SELL	$2.22 - $4.47 $28,116 - $56,612	-12,665 Reduced 56.51%	9,745 $40,000
Q4 2021 Feb 11, 2022	BUY	$2.2 - $4.46 $49,302 - $99,948	22,410 New	22,410 $57,000

2.2K

Ticker GMDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,319,600
Market Cap $2.29M
Description
Gamida Cell Ltd., a clinical-stage biopharmaceutical company, develops cell therapies to cure blood cancers and serious hematologic diseases. The company's lead product candidate is omidubicel, a cell therapy that has completed Phase III clinical trial in patients with high-risk hematologic malignancies, as well as in Phase I/II clinical trials ...

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

Stay updated on Group One Trading, L.P. with notifications on news.